Literature DB >> 22584201

Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.

O Rasslan1, S F Hafez, M Hashem, O I Ahmed, M A S Faramawy, W S Khater, D A Saleh, M I Mohamed, M A M Khalifa, F A Shoukry, E H El-Moghazy.   

Abstract

BACKGROUND: Early detection of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) is of primary importance for both patient management and infection control. Optimal methods for identifying MDR-TB in a timely and affordable manner in resource-limited settings are not yet available.
OBJECTIVES: To evaluate the performance of a low-technology but rapid drug susceptibility testing method, the microscopic observation drug susceptibility assay (MODS), in the concurrent detection of M. tuberculosis and its susceptibility to isoniazid (INH) and rifampin (RMP) directly from sputum specimens.
METHODS: A total of 115 smear-positive TB patients admitted to Abbasia Chest Hospital, Cairo, Egypt, were simultaneously tested using MODS and the BACTEC MGIT 960 mycobacterial detection system for the detection of M. tuberculosis and the identification of MDR-TB samples.
RESULTS: MODS detected 112 (97.4%) samples and BACTEC MGIT detected 115 (100%). Of the 115 isolates tested for susceptibility to INH, RMP and MDR-TB, complete agreement between MODS and MGIT results was found among respectively 92.9%, 95.5% and 97.3% of samples. The sensitivity, specificity, and positive and negative predictive values of MODS in the detection of MDR-TB were respectively 95.3%, 98.6%, 97.6% and 97.1%. MODS results were obtained in a median of 8 days (range 5-21).
CONCLUSION: MODS is an optimal alternative method for timely and affordable identification of MDR-TB in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584201     DOI: 10.5588/ijtld.11.0547

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.

Authors:  M Sanogo; B Kone; B Diarra; M Maiga; B Baya; A M Somboro; Y S Sarro; A C G Togo; B P P Dembele; D Goita; A Kone; O M'Baye; N Coulibaly; S Diabate; B Traore; M H Diallo; Y I Coulibaly; P Saleeb; M Belson; S Orsega; S Siddiqui; M A Polis; S Dao; R L Murphy; S Diallo
Journal:  Clin Microbiol Infect       Date:  2017-01-18       Impact factor: 8.067

2.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

3.  Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.

Authors:  Irina Kontsevaya; Jim Werngren; Yen Holicka; Kadri Klaos; Anh Tran; Vladyslav Nikolayevskyy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-30       Impact factor: 3.267

4.  Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Authors:  Daniela E Kirwan; Cesar Ugarte-Gil; Robert H Gilman; Luz Caviedes; Hasan Rizvi; Eduardo Ticona; Gonzalo Chavez; José Luis Cabrera; Eduardo D Matos; Carlton A Evans; David A J Moore; Jon S Friedland
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.